Focus Taiwan App
Download

Taiwan approves boosters for 5-11 age group, expands 4th dose eligibility

06/27/2022 05:35 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taiwan's Advisory Committee on Immunization Practices (ACIP) on Monday approved the use of the Moderna vaccine for children under 5 years old, booster shots for the 5-11 age group, the Novavax vaccine for those 18 and above, and expanded the eligibility of second booster shots.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.43